ANNA MYERS: Open Payments
NPI 1821430620 · RICHFIELD, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,235 in 51 payments from 15 companies in 2025. Trend: 2023 $12,828 · 2024 $2,540 · 2025 $3,235
Speaker / faculty: $1,725Food & beverage: $1,263Education: $247
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 12 | $2,145 |
| Sumitomo Pharma America, Inc. | 12 | $237 |
| BLUEWIND MEDICAL | 3 | $186 |
| ConvaTec Inc. | 2 | $177 |
| Janssen Biotech, Inc. | 6 | $166 |
| ABBVIE INC. | 2 | $56 |
| Boston Scientific Corporation | 3 | $43 |
| Olympus America Inc. | 2 | $40 |
| UROGEN PHARMA, INC. | 2 | $40 |
| Antares Pharma, Inc. | 2 | $39 |
Products named: Veozah, GEMTESA, REVI, GENTLECATH GLIDE, ERLEADA, RYBREVANT, BOTOX, Axonics.
Industry payments across OH — which companies pay providers there.
